Session

PP 02 H. pylori (Posters)

EFFECTIVENESS OF THE RECOMMENDED THERAPEUTIC PROTOCOLS IN HELICOBACTER PYLORI ERADICATION: A SINGLE CENTRE TEN-YEAR EXPERIENCE
EFFECTIVENESS OF THE RECOMMENDED THERAPEUTIC PROTOCOLS IN HELICOBACTER PYLORI ERADICATION: A SINGLE CENTRE TEN-YEAR EXPERIENCE

SIXTH-LINE ERADICATION THERAPY AGAINST HELICOBACTER PYLORI INFECTION: PRELIMINARY DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
SIXTH-LINE ERADICATION THERAPY AGAINST HELICOBACTER PYLORI INFECTION: PRELIMINARY DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND GASTROESOPHAGEAL REFLUX DISEASE: MENDELIAN RANDOMIZATION STUDY
ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND GASTROESOPHAGEAL REFLUX DISEASE: MENDELIAN RANDOMIZATION STUDY

EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES
EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES

CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

CLINICOPATHOLOGICAL FEATURES AND SERUM RISK MARKERS OF METACHRONOUS GASTRIC CANCER AFTER ERADICATION
CLINICOPATHOLOGICAL FEATURES AND SERUM RISK MARKERS OF METACHRONOUS GASTRIC CANCER AFTER ERADICATION

PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

SAFETY AND EFFECTIVENESS OF VONOPRAZAN AND AMOXICILLIN DUAL REGIMEN WITH SACCHAROMYCES BOULARDII SUPPLEMENTATION AS A RESCUE THERAPY FOR HELICOBACTER PYLORI INFECTION: A PILOT STUDY
SAFETY AND EFFECTIVENESS OF VONOPRAZAN AND AMOXICILLIN DUAL REGIMEN WITH SACCHAROMYCES BOULARDII SUPPLEMENTATION AS A RESCUE THERAPY FOR HELICOBACTER PYLORI INFECTION: A PILOT STUDY

HELICOBACTER PYLORI INFECTION DIAGNOSIS AND MANAGEMENT: CURRENT PRACTICES OF GREEK GASTROENTEROLOGISTS
HELICOBACTER PYLORI INFECTION DIAGNOSIS AND MANAGEMENT: CURRENT PRACTICES OF GREEK GASTROENTEROLOGISTS

Item 41 - 50 / 50
1 2
3